STEPHANIE FOUTS: Open Payments
NPI 1104471978 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 83 payments from 36 companies in 2025. Trend: 2023 $1,244 · 2024 $1,291 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $186 |
| Novartis Pharmaceuticals Corporation | 9 | $174 |
| Janssen Biotech, Inc. | 11 | $165 |
| Ipsen Biopharmaceuticals, Inc | 1 | $116 |
| BeOne Medicines USA, Inc. | 6 | $115 |
| Genentech USA, Inc. | 4 | $97 |
| Daiichi Sankyo Inc. | 4 | $96 |
| Stemline Therapeutics Inc. | 4 | $94 |
| SOBI, INC | 2 | $61 |
| Incyte Corporation | 3 | $60 |
Products named: Onivyde, ENHERTU, BRUKINSA, Fabhalta, Orserdu, KEYTRUDA, RYBREVANT, DARZALEX.
Industry payments across AL — which companies pay providers there.
